Nieuws
EMA brochure 'From lab to patient'
EMA has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU:
Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules derived from human kidney adult stem cells in microfluidic chips. This research has been published in Nature Biotechnology by the world-leading research group from Professor Hans Clevers.
32 scientists to receive NWO Vici grants worth 1.5 million euros
32 leading scientists will each receive 1.5 million euros from the Netherlands Organisation for Scientific Research (NWO). This Vici grant will enable them to develop an innovative line of research and set up their own research group in the coming five years.New accelerator programme for future BioBusiness Leaders in Life Sciences & Health
A new training & mentoring programme to accelerator the development of the next generation BioBusiness Leaders in Life Sciences & Health is launched this year by HELIS Academy. This programme, named TAP BioBusiness is an intensive 8-month programme.
HUB and Yamaha Motor Combine their Proprietary Technologies
Hubrecht Organoid Technology (HUB) and Yamaha Motor have announced their collaboration to provide solutions that deepen our understanding in predictive diagnostic of patients.
Apply now for the European Enterprise Promotion Awards (EEPA)
Succesvol ondernemerschap beloont zichzelf. Maar wie beloont degenen die met creatieve en inspirerende initiatieven ondernemerschap stimuleren? Met de Europese Awards voor Ondernemerschapsbevordering (EEPA) erkent en beloont de Europese Commissie successen van openbare instanties en publiek-private samenwerkingsverbanden. Het doel is ondernemerschap te bevorderen.
Sapreme Technologies in a 6.8 M€ EU alliance to develop an oligonucleotide delivery platform
Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 M€ grant together with a multidisciplinary consortium including 11 other academic and industrial parties.DSM Venturing invests in skin microbiome research
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announced that DSM Venturing, its venture investment arm, has made an equity investment in skin microbiome company S-Biomedic NV. This investment completes S-Biomedic’s latest Series A financing round.Vote now for the National Healthcare Innovation Prize 2019
Tijdens de nationale eHealthweek vonden de regionale voorrondes plaats van de Nationale Zorginnovatieprijs 2019. Dit leverde 10 genomineerden op voor de Nationale Zorginnovatieprijs 2019. Deze 10 genomineerden gaan door naar de finale op 14 maart 2019 tijdens het Health Valley Event in pathé Nijmegen. Breng nu je stem uit!
Venture Challenge Fall 2018 winner SeraNovo receives UNIIQ investment
SeraNovo, een Leidse startup die een nieuw platform voor medicijnformulering ontwerpt, heeft een investering van € 300.000 ontvangen uit het Zuid-Hollandse investeringsfonds UNIIQ. De technologie van SeraNovo maakt het mogelijk om medicatie op een andere manier op te lossen, waardoor medicatie beter opgenomen kan worden door de patiënt.